Hrabálek L, Bacovský J, Scudla V, Wanek T, Kalita O
Neurochirurgická klinika FN a LF UP Olomouc.
Rozhl Chir. 2011 May;90(5):270-6.
The management of spinal multiple myeloma (MM) is a complex process, including causal treatment (i.e. efforts to suppress the tumor clone), as well as supportive therapy, including surgery. The aim of this article is to present retrospective evaluation of surgical indications in patients with MM or solitary spinal plasmocytoma.
A total of 10 patients (8 males and 2 females) aged from 32 to 74 years (the mean age of 53.3) were included in the study. The enrolment criteria were the following: patients operated for MM or solitary spinal plasmocytoma during the past 7-year period, with the minimum follow up period of 6 months. The procedures were indicated for progressing neurological deficit (Frankel score) and for axial spinal pain (VAS classification), not responding to conservative therapy. The extent of the disease was assessed based on plain x-ray, MRI and whole- body 18F-FDG PET/CT. Paliative vertebroplasty was indicated in patients with no neurological deficit to control pain, paliative laminectomy without stabilization in subjects with partial neurological lesions, with transpedicular fixation in concomitant pathological fractures or kyphotizations. More radical approach, i.e. the procedure included somatectomy, was indicated in patients with solitary plasmocytoma and in procedures on cervical or thoracolumbar regions. Control clinical and MRI examinations were performed at 6 weeks, at 6 months and then at yearly intervals. At the end of the study, the authors evaluated effectivity of the employed surgical procedures, based on all control findings, and the data were compared with prognostic scoring systems in surgery for spinal metastases (Tomita score, Tokuhashi modified score and Bauer score).
No local relapses of the tumor or stabilization failure were detected. The effect of surgery on pain control and on prevention of neurological dysfunction was maintained over the follow up period. The authors concluded that all surgical procedures and their radicality were adequate in all subjects. The agreement between the authors approach (the procedure's radicality) and the Tomita score, the Tokuhashi modified score and the Bauer score were recorded in 50% of patients, 80% of patients and in 50% of patients, respectively.
MM is characterized by increased oseteolysis, which is not followed by new bone formation. Despite successful conservative therapy of MM, the bone defects fail to heal, cause spinal pain and may result in spinal instability. These specific MM signs represent the principal factor in the decision- making process concerning indication for surgery. Furthermore, favourable prognosis, with survival times usually exceeding the required expected minimum survival time of 3-6 months, is yet another reason for indication for surgical therapy in patients with spinal MM. Due to advances in chemotherapy and the use of autologic grafts of peripheral stem cells and radiotherapy, the prognosis of patients have significantly improved in last 10 years. The mean survival time has increased from 2.5 years to 4.5 years.
脊柱多发性骨髓瘤(MM)的治疗是一个复杂的过程,包括病因治疗(即抑制肿瘤克隆的努力)以及支持性治疗,其中包括手术。本文的目的是对MM或孤立性脊柱浆细胞瘤患者的手术指征进行回顾性评估。
本研究共纳入10例患者(8例男性,2例女性),年龄在32至74岁之间(平均年龄53.3岁)。纳入标准如下:在过去7年期间因MM或孤立性脊柱浆细胞瘤接受手术,且随访期至少6个月。手术指征为进行性神经功能缺损(Frankel评分)和轴向脊柱疼痛(VAS分级),对保守治疗无效。根据X线平片、MRI和全身18F-FDG PET/CT评估疾病范围。对于无神经功能缺损的患者,采用姑息性椎体成形术控制疼痛;对于部分神经损伤的患者,采用无内固定的姑息性椎板切除术;对于伴有病理性骨折或后凸畸形的患者,采用经椎弓根内固定术。对于孤立性浆细胞瘤患者以及颈椎或胸腰段手术,采用更激进的方法,即包括体切除术。在术后6周、6个月及之后每年进行临床和MRI对照检查。在研究结束时,作者根据所有对照结果评估所采用手术的有效性,并将数据与脊柱转移瘤手术的预后评分系统(Tomita评分、Tokuhashi改良评分和Bauer评分)进行比较。
未检测到肿瘤局部复发或内固定失败。在随访期间,手术对疼痛控制和预防神经功能障碍的效果得以维持。作者得出结论,所有手术及其激进程度对所有患者均足够。作者的方法(手术的激进程度)与Tomita评分、Tokuhashi改良评分和Bauer评分的一致性分别在50%的患者、80%的患者和50%的患者中得到记录。
MM的特征是骨溶解增加,且无新骨形成。尽管MM的保守治疗取得成功,但骨缺损无法愈合,导致脊柱疼痛,并可能导致脊柱不稳定。这些MM的特定体征是手术指征决策过程中的主要因素。此外,预后良好,生存时间通常超过所需的预期最短生存时间3至6个月,这是脊柱MM患者手术治疗指征的另一个原因。由于化疗的进展以及外周干细胞自体移植和放疗的应用,患者的预后在过去10年中显著改善。平均生存时间从2.5年增加到4.5年。